Vetrone, Lorenzo M.
Zaccardi, Francesco http://orcid.org/0000-0002-2636-6487
Webb, David R.
Seidu, Sam
Gholap, Nitin N.
Pitocco, Dario
Davies, Melanie J.
Khunti, Kamlesh
Funding for this research was provided by:
National Institute for Health Research
Article History
Received: 27 September 2018
Accepted: 6 November 2018
First Online: 19 November 2018
Compliance with ethical standards
:
: Data and statistical codes are available on request from the corresponding author (FZ).
: KK has acted as a consultant and speaker for Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp and Dohme. He has received grants in support of investigator and investigator initiated trials from Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Pfizer, Boehringer Ingelheim and Merck Sharp and Dohme. KK has received funds for research, honoraria for speaking at meetings and has served on advisory boards for Lilly, Sanofi-Aventis, Merck Sharp and Dohme and Novo Nordisk. MJD has acted as consultant, advisory board member and speaker for Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp and Dohme, Boehringer Ingelheim, AstraZeneca and Janssen, an advisory board member for Servier and as a speaker for Mitsubishi Tanabe Pharma Corporation and Takeda Pharmaceuticals International Inc. She has received grants in support of investigator and investigator initiated trials from Novo Nordisk, Sanofi-Aventis, Lilly, Boehringer Ingelheim and Janssen. DRW has received grants in support of investigator-initiated studies and honoraria from Sanofi-Aventis and Novo Nordisk. SS has received honoraria for speaking at meetings and serving on Advisory Boards for Novartis, Novo Nordisk, Janssen, MSD, Lilly, and Boehringer Ingelheim. FZ has received honoraria for speaking at meetings for NAPP Pharmaceuticals. LMV, NNG, DP: no relevant conflict of interest.
: This article does not contain any studies with human participants performed by any of the authors.
: For this type of study, formal consent is not required.